FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016609595> ?p ?o ?g. }

• W2016609595 endingPage "957" @default.
• W2016609595 startingPage "947" @default.
• W2016609595 abstract "Invasive fungal infections (IFI) parallel the explosive increase in the immunocompromized patient population, and are characterized by diagnostic difficulties and extreme mortality. Candidemia in a tertiary referral hospital in the Middle East confirms the current epidemiologic shift in this common blood stream pathogen towards non-malignancy cases (38%) and antifungal prophylaxis failure (20%), high presentation sepsis scores and attributable mortality (32%). Invasive aspergillosis (IA) is also associated with high mortality. Use of non-invasive computerized tomographic (CT) radiologic scanning linked to early administration of high dose liposomal amphotericin B (LAB) is associated with a reduced mortality of 9.5% compared to historical experience of 28%.Life threatening invasive aspergillosis also occurs in patients who are less obviously immunocompromized. Investigations may reveal subtle immune deficits which could place the patient at some risk for an invasive mycosis. Antifungal treatment used in combination with progenitor cell growth factors and gamma-interferon has proved successful in such situations of progressive fungal disease unresponsive to antifungal therapy alone. Pharmacologic remodeling of existing compounds by lipidisation reduces both the toxicity denominator and the efficacy numerator of the therapeutic index when compared to the parent drug. A comparative dose study of liposomal amphotericin B in aspergillosis has demonstrated equi-efficacy, generated debate over the ability of the controlled clinical trial to be capable of assessing antifungal efficacy, and illustrated that recovery from an invasive fungal infection may require maximum tolerated doses and immunomanipulation. Several new antifungal strategies are under clinical investigation. These include reformulating existing antifungals, exploitation of the growing knowledge of virulence factors to synthesize antagonists, immune reconstitution and immunoprotection. An interim analysis of an ongoing placebo controlled study of recombinant interleukin-11 to assess its efficacy in reducing sepsis in leukemia patients through prevention of chemotherapy induced gut epithelial cell apoptosis, has demonstrated a difference in the two study arms in sepsis rates and preservation of gastrointestinal epithelial cell integrity. The unique and special challenges presented by the dynamic epidemiologics of invasive fungal infections are demanding and attracting considerable responses, in the fields of diagnosis and therapeutics. Current strategies need considerable improvement, yet ongoing collaborative efforts will have a positive impact on our understanding of the fungus-host interaction and ultimately our ability to offer better care for our patients with invasive mycoses." @default.
• W2016609595 created "2016-06-24" @default.
• W2016609595 creator A5039035175 @default.
• W2016609595 date "2002-05-01" @default.
• W2016609595 modified "2023-09-24" @default.
• W2016609595 title "Invasive fungal infections: evolving challenges for diagnosis and therapeutics" @default.
• W2016609595 cites W1899514055 @default.
• W2016609595 cites W1908952024 @default.
• W2016609595 cites W1939669701 @default.
• W2016609595 cites W1968717829 @default.
• W2016609595 cites W1979113397 @default.
• W2016609595 cites W1986330094 @default.
• W2016609595 cites W1993710278 @default.
• W2016609595 cites W1998840608 @default.
• W2016609595 cites W2006777677 @default.
• W2016609595 cites W2008145508 @default.
• W2016609595 cites W2015008429 @default.
• W2016609595 cites W2018691301 @default.
• W2016609595 cites W2029796144 @default.
• W2016609595 cites W2031875942 @default.
• W2016609595 cites W2040405627 @default.
• W2016609595 cites W2045138757 @default.
• W2016609595 cites W2056487322 @default.
• W2016609595 cites W2070900392 @default.
• W2016609595 cites W2074211066 @default.
• W2016609595 cites W2078204932 @default.
• W2016609595 cites W2082528628 @default.
• W2016609595 cites W2084450020 @default.
• W2016609595 cites W2085440534 @default.
• W2016609595 cites W2095696028 @default.
• W2016609595 cites W2098563304 @default.
• W2016609595 cites W2101504223 @default.
• W2016609595 cites W2102993886 @default.
• W2016609595 cites W2103371583 @default.
• W2016609595 cites W2103713801 @default.
• W2016609595 cites W2111992811 @default.
• W2016609595 cites W2125313416 @default.
• W2016609595 cites W2126536749 @default.
• W2016609595 cites W2129948097 @default.
• W2016609595 cites W2130882795 @default.
• W2016609595 cites W2131936678 @default.
• W2016609595 cites W2135352158 @default.
• W2016609595 cites W2141436450 @default.
• W2016609595 cites W2143326683 @default.
• W2016609595 cites W2146052740 @default.
• W2016609595 cites W2153548320 @default.
• W2016609595 cites W2160185453 @default.
• W2016609595 cites W2163206122 @default.
• W2016609595 cites W2163704245 @default.
• W2016609595 cites W2204864051 @default.
• W2016609595 cites W2258562956 @default.
• W2016609595 cites W2326799365 @default.
• W2016609595 cites W2339763729 @default.
• W2016609595 cites W3113172526 @default.
• W2016609595 cites W4252230400 @default.
• W2016609595 cites W63034058 @default.
• W2016609595 doi "https://doi.org/10.1016/s0161-5890(02)00022-6" @default.
• W2016609595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12009573" @default.
• W2016609595 hasPublicationYear "2002" @default.
• W2016609595 type Work @default.
• W2016609595 sameAs 2016609595 @default.
• W2016609595 citedByCount "70" @default.
• W2016609595 countsByYear W20166095952012 @default.
• W2016609595 countsByYear W20166095952013 @default.
• W2016609595 countsByYear W20166095952014 @default.
• W2016609595 countsByYear W20166095952016 @default.
• W2016609595 countsByYear W20166095952017 @default.
• W2016609595 countsByYear W20166095952019 @default.
• W2016609595 countsByYear W20166095952020 @default.
• W2016609595 countsByYear W20166095952021 @default.
• W2016609595 countsByYear W20166095952022 @default.
• W2016609595 countsByYear W20166095952023 @default.
• W2016609595 crossrefType "journal-article" @default.
• W2016609595 hasAuthorship W2016609595A5039035175 @default.
• W2016609595 hasConcept C126322002 @default.
• W2016609595 hasConcept C16005928 @default.
• W2016609595 hasConcept C177713679 @default.
• W2016609595 hasConcept C203014093 @default.
• W2016609595 hasConcept C2776391196 @default.
• W2016609595 hasConcept C2779548794 @default.
• W2016609595 hasConcept C2779629538 @default.
• W2016609595 hasConcept C2780908437 @default.
• W2016609595 hasConcept C2908647359 @default.
• W2016609595 hasConcept C2991737395 @default.
• W2016609595 hasConcept C71924100 @default.
• W2016609595 hasConcept C99454951 @default.
• W2016609595 hasConceptScore W2016609595C126322002 @default.
• W2016609595 hasConceptScore W2016609595C16005928 @default.
• W2016609595 hasConceptScore W2016609595C177713679 @default.
• W2016609595 hasConceptScore W2016609595C203014093 @default.
• W2016609595 hasConceptScore W2016609595C2776391196 @default.
• W2016609595 hasConceptScore W2016609595C2779548794 @default.
• W2016609595 hasConceptScore W2016609595C2779629538 @default.
• W2016609595 hasConceptScore W2016609595C2780908437 @default.
• W2016609595 hasConceptScore W2016609595C2908647359 @default.
• W2016609595 hasConceptScore W2016609595C2991737395 @default.
• W2016609595 hasConceptScore W2016609595C71924100 @default.
• W2016609595 hasConceptScore W2016609595C99454951 @default.

• next